Crossmark

Long-term visual, refractive, tomographic and aberrometric outcomes of corneal collagen crosslinking (CXL) with or without hypoosmolar riboflavin solution in the treatment of progressive keratoconus patients with thin corneas

Crossref DOI link: https://doi.org/10.1007/s00417-021-05314-w

Published Online: 2021-11-27

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Celik Buyuktepe, Tuna https://orcid.org/0000-0002-2383-0029
Ucakhan, Omur O. https://orcid.org/0000-0002-3447-7785
Funding

Funding for this research was provided by:

Ankara Universitesi
License Information

Text and Data Mining valid from 2021-11-27

Version of Record valid from 2021-11-27
More Information

Article History

Received: 20 January 2021

Revised: 27 June 2021

Accepted: 1 July 2021

First Online: 27 November 2021

Declarations

:

: This retrospective study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of Ankara University approved this study (date: 29.04.2020, number: İ4-228–20).

: Informed consent was obtained from each patients’ guardian or patient included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below